Zhen Su's most recent trade in Karyopharm Therapeutics Inc was a trade of 4,600 Nonstatutory Stock Option (right to buy) done . Disclosure was reported to the exchange on May 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Karyopharm Therapeutics Inc | Zhen Su | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 4,600 | 4,600 | - | - | Nonstatutory Stock Option (right to buy) | |
| Karyopharm Therapeutics Inc | Zhen Su | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 50,587 | 50,587 | - | - | Nonstatutory Stock Option (right to buy) |